Arthur J. Gallagher & Co. (AJG)
(Real Time Quote from BATS)
$286.16 USD
+4.91 (1.75%)
Updated Aug 7, 2024 11:38 AM ET
2-Buy of 5 2
F Value F Growth D Momentum F VGM
Fundamental Charts
About PEG Ratio (TTM)
The company's trailing twelve month (TTM) PEG ratio is the P/E ratio divided by its long-term growth rate consensus. This ratio essentially compares the P/E to its growth rate, thus, for many, telling a more complete story than just the P/E ratio alone. Conventional wisdom says that a PEG ratio of 1 or less is considered good (at par or undervalued to its growth rate). A value greater than 1, in general, is not as good (overvalued to its growth rate). For example, a company with a P/E ratio of 25 and a growth rate of 20% would have a PEG ratio of 1.25 (25 / 20 = 1.25). A company with a P/E ratio of 40 and a growth rate of 50% would have a PEG ratio of 0.80 (40 / 50 = 0.80). Traditionally, investors would look at the stock with the lower P/E and deem it a bargain. But when compared to its growth rate, it doesn't have the earnings growth to justify its P/E. In this example, the one with the P/E of 40 is the better bargain because it is selling at a discount to its growth rate. So the PEG ratio tells you what you're paying for each unit of earnings growth.
AJG 286.16 +4.91(1.75%)
Will AJG be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for AJG based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for AJG
Arthur J. Gallagher (AJG) is a Great Momentum Stock: Should You Buy?
Arthur J. Gallagher (AJG) Moves to Buy: Rationale Behind the Upgrade
AJG: What are Zacks experts saying now?
Zacks Private Portfolio Services
Is Arthur J. Gallagher & Co. (AJG) Outperforming Other Finance Stocks This Year?
Arthur J. Gallagher (AJG) Q2 Earnings Beat Estimates, Rise Y/Y
Arthur J. Gallagher (AJG) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates
Other News for AJG
(AJG) - Analyzing Arthur J. Gallagher's Short Interest
Trump Media Stock: Is the Name Really Worth $5 Billion? Not One Bit. Here’s Why
Argus Research Remains a Buy on Arthur J Gallagher & Co (AJG)
GLP-1s, Surging Medical Costs Have Employers Taking a Hard Look at the Return on Investment
Arthur J. Gallagher price target raised by $10 at Truist, here's why